Nelson, Н. D., et al. «Postmenopausal Hormone Replacement Therapy: Scientific Review», Journal of the American Medical Association 288 (2002): 872–81.
Riley, K. P., et al. «Cognitive Function and Apolipoprotein E in Very Old Adults: Findings from the Nun Study», Journal of Gerontology, Series В-Psychological Sciences and Social Sciences 55, no. 2 (March 2000): S69–75.
Ruitenberg, A., et al. «Alcohol Consumption and Risk of Dementia: The Rotterdam Study», Lancet 359 (2002): 281–86.
Selkoe, D. J., «AD: Genotypes, Phenotype and Treatment», Science 275 (1997): 630–31.
Seshadri, S., et al. «Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer’s Disease», New England Journal of Medicine 346 (2002): 476–83.
Shankle, W. R., and D. G. Amen, «Preventing Alzheimer’s: Ways to Prevent, Delay or Halt Alzheimer’s and Other Forms of Memory Loss» (New York: Putnam, 2004).
Shankle, W. R., M. S. Rafii, and В. H. Landing, «Functional Relationships Associated with Pattern of Development in Developing Human Cerebral Cortex», Concepts in Neuroscience 4, no. 1 (1993): 77–87.
Shankle, W. R., et al. «Numbers of Neurons Per Column in the Developing Human Cerebral Cortex from Birth to 72 Months: Evidence for an Apparent Post-Natal Increase in Neuron Numbers», Journal of Theoretical Biology 191 (1998): 115–40.
Tang, М. X., et al. «Effect of Age, Ethnicity, and Head Injury on the Association Between APOE Genotypes and Alzheimer’s Disease», Annals of the New York Academy of Sciences 802 (1996): 6–15.
Truelson, T., et al. «Amount and Type of Alcohol and Risk of Dementia: The Copenhagen City Heart Study», Neurology 59 (2002): 1313–19.
Valcour, V. G., et al. «The Detection of Dementia in the Primary Care Setting», Archives of Internal Medicine 160 (2000): 2964–68.
Van Kooten, F., et al. «The Dutch Vascular Factors in Dementia Study: Rationale and Design», Journal of Neurology 245 (1998): 32–39.
Van Dam, F. S., et al. «Impairment of Cognitive Function in Women Receiving Adjuvant Treatment for High-Risk Breast Cancer: High-Dose Versus Standard-Dose Chemotherapy», Journal of the National Cancer Institute 90 (1998): 210–18.
Wilson, R. S., et al. «Participation in Cognitively Stimulating Activities and Risk of Incident Alzheimer Disease», Journal of the American Medical Association 287 (2002): 742–48.
Wilson, R. S., et al. «The Apolipoprotein E Varepsilon 2 Allele and Decline in Episodic Memory», Journal of Neurology, Neurosurgery, Und Psychiatry 73 (2002): 672–77.
Yaffe, K., et al. «Estrogen Receptor 1 Polymorphisms and Risk of Cognitive Impairment in Older Women», Biological Psychiatry 51 (2002): 677–82.
Глава 20
Ацетил-L-карнитин
Brooks, J. О., Ill, et al. «Acetyl-L–Carnitine Slows Decline in Younger Patients with Alzheimer’s Disease: A Reanalysis of a Double-Blind, Placebo-Controlled Trial Using the Trilinear Approach», International Psychogeriatrics 10 (1998): 193–203.
Cipolli, C., and G. Chiari, «Effects of L-Acetyl Carnitine on Mental Deterioration in the Aged: Initial Results», Clinical Therapeutics 132 (1990): 479–510.
Garzya, G., et al. «Evaluation of the Effects of L-Acetyl Carnitine on Senile Patients Suffering from Depression», Drugs Under Experimental and Clinical Research 16 (1990): 101–06.
Gorini, A., A. D'Angelo, and R. F. Villa, «Action of L-Acetyl сarnitine on Different Cerebral Mitochondrial Populations from Cerebral Cortex», Neurochemical Research 23 (1998): 1485–91.
Guarnaschelli, C., G. Fugassa, and C. Pistarini, «Pathological Brain Ageing: Evaluation of the Efficacy of a Pharmacological Aid», Drugs Under Experimental and Clinical Research 14 (1998): 715–18.
Lolic, М. М., G. Fiskum, and R. E. Rosenthal, «Neuroprotective Effects of Acetyl-L–Carnitine After Stroke in Rats», Annals of Emergency Medicine 29 (1997): 758–65.
Patti, F., P. Marano, and S. Cappello, «Effects of L-Acetyl Carnitine on Functional Recovery of Hemiplegic Patients», Clinical Trials Journal 25 (1988): 87–101.
Pettegrew, J. W., W. E. Klunke, and K. Panchalingam, «Clinical and Biochemical Effects of Acetyl-L–Carnitine in Alzheimer’s Disease», Neurobiology of Aging 16 (1998): 1–4.
Rai, G., et al. «Double-Blind, Placebo-Controlled Study of Acetyl-L–Carnitine in Patients with Alzheimer’s Dementia», Current Medical Research and Opinion 11 (1990): 638–47.
Salvioli, G., and M. Neri, «L-Acetyl carnitine Treatment of Mental Decline in the Elderly», Drugs Under Experimental and Clinical Research 20 (1994): 169–76.
Sano, M., et al. «Double-Blind Parallel Pilot Study of Acetyl Levocarnitine in Patients with Alzheimer’s Disease», Archives of Neurology 49 (1992): 1137–41.
Spagnoli, A., et al. «Long-Term Acetyl-L–Carnitine Treatment in Alzheimer’s Disease», Neurology 41 (1991): 1726–32.
Tempesta, E., et al. «Role of Acetyl-L–Carnitine in the Treatment of Cognitive Deficit in Chronic Alcoholism», International Journal of Clinical Pharmacological Research 10 (1990): 101–07.
Tempesta, E., et al. «L-Acetylcarnitine in Depressed Elderly Subjects. A Cross-over Study vs. Placebo», Drugs Under Experimental and Clinical Research 10 (1990): 101–07.
Thai, L. J., et al. «A One Year Multicenter Placebo-Controlled Study of Acetyl-L–Carnitine in Patients with Alzheimer’s Disease», Neurology 47 (1996): 705–11.
Альфа-липоевая кислота
Marangon, K., et al. «Comparison of the Effect of Alpha-Lipoic Acid and Alpha-Tocopherol Supplementation on Measures of Oxidative Stress», Free Radical Biology and Medicine 27(1999): 1114–21.
Packer, L., H.J. Tritschler, and K. Wessel, «Neuroprotection by the Metabolic Antioxidant Alpha-Lipoic Acid», Free Radical Biology and Medicine 22 (1997): 359–78.
Packer, L., E. H. Witt, and H. J. Tritschler, «Alpha-Lipoic as a Biological Antioxidant», Free Radical Biology and Medicine 79 (1995): 227–50.
Poon, Н. F., et al. «Proteomic Analysis of Specific Brain Proteins in Aged SAMP8 Mice Treated with Alpha-Lipoic Acid: Implications for Aging and Age-Related Neuro-degenerative Disorders», Neurochemistry International 46, no. 2 (January 2005): 159–68.
Tirosh, O., et al. «Neuroprotective Effects of Alpha-Lipoic Acid and Its Positively Charged Amide Analogue», Free Radical Biology and Medicine 26 (1999): 1418–26.
Ziegler, D., et al. «Treatment of Symptomatic Diabetic Peripheral Neuropathy with the Antioxidant Alpha-Lipoic Acid. A Three-Week Multicentre Randomized Controlled Trial (ALADIN Study)», Diabetologia 38 (1995): 1425–33.
